Ethinylestradiol/desogestrel - Teva

Drug Profile

Ethinylestradiol/desogestrel - Teva

Alternative Names: DR-102; DR-1021; LeCette

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Teva Pharmaceutical Industries
  • Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes; Norpregnenes; Oral contraceptives
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pregnancy

Most Recent Events

  • 02 Feb 2014 Teva Pharmaceutical Industries has patent protection for ethinylestradiol/desogestrel in USA
  • 30 Sep 2013 Preregistration for Contraception/Pregnancy (Prevention) in USA (PO)
  • 08 May 2013 Efficacy and adverse events data from a phase I trial in Contraception/Pregnancy (Prevention) released by Teva Pharmaceutical Industries
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top